Ipsen SA

Common Name
Ipsen
Country
France
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Employees
5,358
Ticker
IPN
Exchange
EURONEXT
Description
Ipsen S.A. is a global biopharmaceutical company specializing in the discovery, development, and commercialization of innovative medicines. The firm's primary focus is on specialty care, targeting thr...

Financial Statements of Ipsen

Below are the financial statements of Ipsen, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

All figures in millions of EUR20242023
Sales
3,400.6a
3,127.5a
Other revenues
173.9a
178.9a
Revenue
3,574.5a
3,306.4a
Cost of goods sold
-618.7a
-571.2a
Selling expenses
-957.2a
-917.1a
Research and development expenses
-686.6a
-619.3a
General and administrative expenses
-216.3a
-217.8a
Other operating income
120.6a
62.6a
Other operating expenses
-424.7a
-453.3a
Restructuring costs
-14.1a
-27.7a
Impairment losses
-280.9a
-253.4a
Operating income
496.7a
816a
Net financing costs
-8.6a
-19.4a
Other financial income and expenses
-56.4a
-35.1a
Income taxes
-74.9a
-136.2a
Share of net profit/(loss) from equity-accounted companies
0.5a
-5.4a
Net profit/(loss) from continuing operations
357.3a
619.9a
Net profit/(loss) from discontinued operations
-10a
27.3a
Consolidated net profit
347.3a
647.2a
Attributable to shareholders of Ipsen S.A.
345.9a
644.4a
Attributable to non-controlling interests
1.4a
2.8a

Verified Sources Behind Ipsen’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Ipsen’s data sources below and access millions more through our Disclosure Search.

a. Ipsen's Universal Registration Document (URD) 2024
Trace every data point back to Ipsen’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?